{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T00:03:50Z","timestamp":1705190630462},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1986,1,1]],"date-time":"1986-01-01T00:00:00Z","timestamp":504921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[1986,1]]},"DOI":"10.1016\/0145-2126(86)90103-7","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T09:53:46Z","timestamp":1082714026000},"page":"35-42","source":"Crossref","is-referenced-by-count":5,"title":["Antigenic heterogeneity among burkitt's lymphoma cells surviving treatment with monoclonal antibody and complement"],"prefix":"10.1016","volume":"10","author":[{"given":"Paolo","family":"De Fabritiis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Bregni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Robert C.","family":"Bast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0145-2126(86)90103-7_BIB1","first-page":"1388","article-title":"Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement","volume":"43","author":"Bast","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/0145-2126(86)90103-7_BIB2","first-page":"499","article-title":"Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement","volume":"45","author":"Bast","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/0145-2126(86)90103-7_BIB3","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.4049\/jimmunol.129.3.1336","article-title":"Immunoglobulin secretion by cell lines derived from African and American undifferentiated lymphomas of Burkitt's and Non-Burkitt's type","volume":"129","author":"Benjamin","year":"1982","journal-title":"J. Immun."},{"key":"10.1016\/0145-2126(86)90103-7_BIB4","first-page":"4364","article-title":"Physiochemical and morphological characterization of a new allo transplantable mammary carcinoma ascites subline. TA3-5T\/TICOL\/A","volume":"43","author":"Codington","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/0145-2126(86)90103-7_BIB5","first-page":"728","article-title":"Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens","volume":"43","author":"Hand","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/0145-2126(86)90103-7_BIB6","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0008-8749(81)90470-6","article-title":"Expression of a 26,000 dalton glycoprotein on activated human T cells","volume":"64","author":"Hercend","year":"1981","journal-title":"Cellular Immun."},{"key":"10.1016\/0145-2126(86)90103-7_BIB7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI110005","article-title":"A unique cell surface antigen identifying lymphoid malignancies of B cell origin","volume":"67","author":"Nadler","year":"1981","journal-title":"J. clin. Invest."},{"key":"10.1016\/0145-2126(86)90103-7_BIB8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/283583a0","article-title":"A monoclonal antibody to human acute lymphoblastic leukemia antigen","volume":"283","author":"Ritz","year":"1980","journal-title":"Nature, Lond."},{"key":"10.1016\/0145-2126(86)90103-7_BIB9","first-page":"2369","article-title":"Isolation, karyotype, and clonal growth of heterogenous subpopulations of human malignant gliomas","volume":"41","author":"Shapiro","year":"1981","journal-title":"Cancer Res."},{"key":"10.1016\/0145-2126(86)90103-7_BIB10","first-page":"3327","article-title":"Demonstration of complex antigenic heterogeneity in a human glioma cell line and light derived clones by specific monoclonal antibodies","volume":"43","author":"Wilkstrand","year":"1983","journal-title":"Cancer Res."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212686901037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:0145212686901037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T05:16:09Z","timestamp":1705122969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/0145212686901037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986,1]]}},"alternative-id":["0145212686901037"],"URL":"https:\/\/doi.org\/10.1016\/0145-2126(86)90103-7","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[1986,1]]}}}